Bushman Data

This folder includes all data necessary to reproduce the reported findings. Some files overlap in content but are formatted to facilitate analysis (R code at https://github.com/falciparum/Competition-Analysis.git). Data include parasitemia, genotype, age, location, year of sample collection, microsatellite genotyping results, MOI frequencies, and certain controls used to correct results for mixed-genotype infections

MOESM1 of Efficacy of artemether–lumefantrine, artesunate–amodiaquine, and dihydroartemisinin–piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in Angola, 2015

Additional file 1. Kaplan–Meier estimates of the proportion of participants with adequate clinical and parasitological response (ACPR) over the course of follow up during therapeutic efficacy monitoring in Angola, 2015. AL: Artemether-lumefantrine, ASAQ: Artesunate-amodiaquine, DP: Dihydroartemisinin-piperaquine

MOESM2 of Efficacy of artemether–lumefantrine, artesunate–amodiaquine, and dihydroartemisinin–piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in Angola, 2015

Additional file 2. Lengths of neutral microsatellite markers for late treatment failures and randomly chosen treatment successes, Angola therapeutic efficacy monitoring, 2015

MOESM4 of Efficacy and safety of artemether–lumefantrine, artesunate–amodiaquine, and dihydroartemisinin–piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2017

Additional file 4. Day 7 lumefantrine levels in patients treated with artemether-lumefantrine, by treatment outcome, Zaire, Angola

MOESM2 of Efficacy and safety of artemether–lumefantrine, artesunate–amodiaquine, and dihydroartemisinin–piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2017

Additional file 2. Microsatellite marker results, Angola therapeutic efficacy monitoring, 2017

MOESM1 of Efficacy and safety of artemether–lumefantrine, artesunate–amodiaquine, and dihydroartemisinin–piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2017

Additional file 1. Consort flow diagrams for follow-up outcomes in all six study arms, 2017